特一药业：积极研究海南封关后落地政策

Group 1 - The core viewpoint of the article highlights the positive impact of Hainan's free trade port policies on the biopharmaceutical industry, particularly for Teva Pharmaceutical [2] - The company acknowledges the implementation of supportive policies covering the entire chain of research, innovation, production, and industrial upgrading in Hainan [2] - Teva Pharmaceutical and its subsidiary, Hainan Haili Pharmaceutical, are actively studying the specific policies that will be implemented post the full closure of Hainan, aiming to integrate these opportunities with their existing business and future plans [2] Group 2 - The company expresses its commitment to contributing to the local biopharmaceutical industry's development and participating in Hainan's economic construction [2] - Teva Pharmaceutical assures that it will comply with regulatory requirements and fulfill information disclosure obligations regarding any specific development plans in the future [2]